Preliminary Program
Session times on those days will not be finalized until the overall program schedule is completed.
Program Tracks (Please click each Track for detailed program information) |
Track 2: Breakthroughs in Cancer Prognostics and Diagnostics |
Track 4: Clinical Research
Track 4-1: Radiotherapy
| Time: May 15, 2019 (Wednesday) Place: Suehiro, 4th Floor |
|
|
Chair |
Dr. Marcin Daniel Sawicki, Assistant, University of Rzeszów, Poland |
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Title: Clinical Impact of Approximations in Analytical Dose Computations in Lung Patients Receiving Proton Therapy |
|
14:00-14:25 |
Title: Modern Techniques of Applications in Brachytherapy Hdr Based on Three-Dimensional Imaging |
|
14:25-14:50 |
Title: BRAF and Molecular Mechanisms Responsible for Radiation Resistance in Colorectal Tumours |
| 14:50-15:15 | Title: Audits in Radiation Oncology - Design, Performance, Evaluation Dr. Irena Koniarova, National Radiation Protection Institute, Czech Republic |
|
15:15-15:30 |
Coffee Break |
|
15:30-15:55 |
Title: The Effect of Albumins on Photophysical Characteristics of Photosensitizers for Cancer Photochemotherapy |
|
15:55-16:20 |
Title: Cancer Precision Medicine/Pernonalized Therapy |
Track 4-2: Surgical Therapy and Combination Therapy
| Time: May 16, 2019 (Thursday) Place: Heian North, 4th Floor |
|
|
Chair |
Dr. Vinod K Prasad, Director, PBMT Fellowship, Duke University Medical Center, USA |
|
09:00-09:05 |
Chair's Introduction |
|
09:05-09:30 |
Title: Excellent Outcomes of Hematopoietic Stem Cell Transplantation in Childhood Leukemia |
|
09:30-09:55 |
Title: Curative Intended Treatment Options in Isolated Esophageal Cancer Regrowth |
|
09:55-10:20 |
Title: TAFRO Syndrome Presenting with Membranoproliferative Glomerulonephritis-like Findings: It might be Related to Castleman Disease |
|
10:20-10:45 |
Title: RENCA Macrobead Therapy: A Systems-Biology Approach to mCRC Patients - Phase II Preliminary Data Findings |
|
10:45-11:10 |
Title: A Pilot Trial Assessing Apatinib Combined with or without Radiotherapy for Heavily Treated Head and Neck Squamous Cell Carcinoma |
Track 4-3: Cancer Rehabilitation, Cancer Nursing and Psycho-Oncology
|
Time: May 17, 2019 (Friday) |
|
|
Chair |
Dr. Margaret I. Fitch, Professor, University of Toronto, Canada |
|
09:00-09:05 |
Chair's Introduction |
| 09:05-09:30 | Title: Caring for Older Adults with Cancer: A Need for Collaboration Dr. Margaret I. Fitch, Professor, University of Toronto, Canada |
|
09:30-09:55 |
Title: Oncologic Emergencies in the Patient with a Solid Tumor |
|
09:55-10:20 |
Title: The Role of Topiceuticals in Cancer Pain |
|
10:20-10:45 |
Title: National Early Warning Scores (NEWS): A Quality Improvement Project |
|
10:45-11:00 |
Coffee Break |
|
11:00-11:25 |
Title: Impact of Health Literacy on Outcomes in Patients with Cancer Dr. Carla Schaefer, Associate Director, Nursing Infusion Services, Rutgers Cancer Institute of New Jersey, USA |
|
11:25-11:50 |
Title: The Prevalence and Predictors of Depressive Disorders in Caregivers of Patients with Head and Neck Cancer: A Six-Month Follow-Up Study |
|
11:50-12:15 |
Title: The Efficacy of a Mindfulness Based Intervention (MBI) on Emotional Adjustment and Immune Response in Women with Breast Cancer |
| 12:15-12:40 |
Title: Nursing Management of Patients with Advanced Pancreatic Cancer plus Abdominal Pain Undergoing Endoscopic Ultrasound-Guided Celiac Plexus Neurolysis |
BIT Group Global Ltd.
Japan-China Business Co., Ltd.
日中商務株式会社
Dr. Vladimir Lazar
Chief Scientific and Operating Officer
WIN Consortium, France
Dr. Ashok Srivastava
Chief Executive Officer & Chief Medical Officer, ClinFomatrix, Cure Pharmaceuticals, Inc, USA
Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2008-2019 BIT Congress Inc.